Calicivirus (Genus Vesivirus) associated with post-transfusional hepatitis

Douglas E. Skilling , Alvin Smith , Karen Bok , Chet C. Smith

2007
Antisense antiviral compounds and methods for treating foot and mouth disease

Dwight D. Weller , Ariel E. Vagnozzi , David A. Stein , Patrick L. Iversen

7
2006
47
2003
Antisense restenosis composition and method

Patrick L. Iversen , Dwight D. Weller

48
2006
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells

Patrick L. Iversen , Andrew D. Kroeker , Michelle H. Nelson , Hong M. Moulton

2004
c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.

Patrick L. Iversen , Derek C. Knapp , Muralimohan T. Reddy , Vikram Arora
Journal of Pharmacology and Experimental Therapeutics 292 ( 3) 921 -928

74
2000
Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo.

Patrick L. Iversen , Vikram Arora
Drug Metabolism and Disposition 28 ( 2) 131 -138

28
2000
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.

Patrick L. Iversen , Gayathri R. Devi , Carla A. London , Adams Amantana
Molecular Cancer Therapeutics 3 ( 6) 699 -707

138
2004
Peptide conjugated, inosine-substituted antisense oligomer compound and method

Patrick L. Iversen , Dwight D. Weller , Jed N. Hassinger

35
2005
Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Patrick L. Iversen , Vikram Arora , Gayathri R. Devi , David H. Mason
Clinical Cancer Research 9 ( 7) 2510 -2519

117
2003
Splice-region antisense composition and method

Patrick L. Iversen , Robert M. Hudziak

79
2001